Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab
Annular Elastolytic Giant Cell Granuloma Successfully Treated With Adalimumab Subsequently Complicated by Drug-Induced Lupus - JDDonline - Journal of Drugs in Dermatology
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
Clinical findings of the patient. (A) Erythematous scaly papules and... | Download Scientific Diagram
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
The best combination for the treatment of Hidradenitis Suppurativa - Dr. Anuj Pall MD, PhD - YouTube
Treatment of Recalcitrant Generalized Granuloma Annulare With Adalimumab - JDDonline - Journal of Drugs in Dermatology
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™ - iData Research
View Image
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
Dermatologic Therapy: Vol 33, No 3
Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis
Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy | HTML | Acta Dermato-Venereologica
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - ScienceDirect
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
![PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5bf0a699fddfc4f70f2e2049b59250c0f12b4210/2-Figure1-1.png "PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar")
PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
